Search research articles
Contact Us
Filters
Showing results (201-210 of 404) with videos related to
Page
of 41
Sort By:
AIDS (London, England)
|
March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
Gregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
Plos One
|
June 5, 2014
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012
Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, et al.
JHEP Reports : Innovation in Hepatology
|
September 19, 2022
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales
Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
International Journal of Epidemiology
|
October 16, 2003
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001
Matthew G Law, Gregory J Dore, Nicky Bath, et al.
Health Science Reports
|
April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial
Jason Grebely, Phillip Read, Evan B Cunningham, et al.
The Journal of Infectious Diseases
|
March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design
Peter Vickerman, Jason Grebely, Gregory J Dore, et al.
Virology Journal
|
February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
Behzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Journal of Hepatology
|
November 28, 2012
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection
Matthew T Kitson, Gregory J Dore, Jacob George, et al.
JHEP Reports : Innovation in Hepatology
|
March 14, 2024
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]
Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Viral Hepatitis
|
November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study
Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Page
of 41
Search research articles
Search
Showing results (201-210 of 404) with videos related to
Sort By:
Page
of 41
AIDS (London, England)
|
March 11, 2010
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption
Gregory J Dore, Vicente Soriano, Jürgen Rockstroh, et al.
Plos One
|
June 5, 2014
Declining incidence of hepatitis C virus infection among people who inject drugs in a Canadian setting, 1996-2012
Jason Grebely, Viviane Dias Lima, Brandon D L Marshall, et al.
JHEP Reports : Innovation in Hepatology
|
September 19, 2022
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales
Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
International Journal of Epidemiology
|
October 16, 2003
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001
Matthew G Law, Gregory J Dore, Nicky Bath, et al.
Health Science Reports
|
April 10, 2020
Elbasvir and grazoprevir for hepatitis C virus genotype 1 infection in people with recent injecting drug use (DARLO-C): An open-label, single-arm, phase 4, multicentre trial
Jason Grebely, Phillip Read, Evan B Cunningham, et al.
The Journal of Infectious Diseases
|
March 30, 2012
The more you look, the more you find: effects of hepatitis C virus testing interval on reinfection incidence and clearance and implications for future vaccine study design
Peter Vickerman, Jason Grebely, Gregory J Dore, et al.
Virology Journal
|
February 26, 2016
Alanine aminotransferase, HCV RNA levels and pro-inflammatory and pro-fibrogenic cytokines/chemokines during acute hepatitis C virus infection
Behzad Hajarizadeh, François Mj Lamoury, Jordan J Feld, et al.
Journal of Hepatology
|
November 28, 2012
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection
Matthew T Kitson, Gregory J Dore, Jacob George, et al.
JHEP Reports : Innovation in Hepatology
|
March 14, 2024
Corrigendum to "Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales" [JHEP Reports 4 (2022)]
Syed Hassan Bin Usman Shah, Maryam Alavi, Behzad Hajarizadeh, et al.
Journal of Viral Hepatitis
|
November 8, 2023
Incidence of hepatitis C virus infection in the prison setting: The SToP-C study
Behzad Hajarizadeh, Joanne M Carson, Marianne Byrne, et al.
Page
of 41